OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
66 hedge funds and large institutions have $135M invested in Osiris Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
94% less call options, than puts
Call options by funds: $404K | Put options by funds: $7.24M
Holders
66
Holding in Top 10
–
Calls
$404K
Puts
$7.24M
Top Buyers
| 1 | +$3.21M | |
| 2 | +$1.52M | |
| 3 | +$1.4M | |
| 4 |
QI
QS Investors
New York
|
+$1.04M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.03M |
Top Sellers
| 1 | -$4.88M | |
| 2 | -$1.18M | |
| 3 | -$1.16M | |
| 4 |
HNB
Huntington National Bank
Columbus,
Ohio
|
-$1.03M |
| 5 |
Barclays
London,
United Kingdom
|
-$516K |